Literature DB >> 19587679

A histone code for the DNA damage response in mammalian cells?

Armelle Corpet1, Geneviève Almouzni.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19587679      PMCID: PMC2711191          DOI: 10.1038/emboj.2009.180

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


× No keyword cloud information.
DNA repair in the context of chromatin represents a challenge both in terms of accessibility to the lesion and maintenance of genome stability. Histones, the main protein component of chromatin, can be subjected to a variety of post-translational modifications (PTMs) that impact on genome function by either directly affecting nucleosome stability or providing a docking site for distinct regulatory proteins. In this issue of EMBO Journal, Tjeertes et al investigate histone PTMs with a specific involvement in the DNA damage response (DDR). After DNA damage, a prominent change at the chromatin level is the increase in H2A.X phosphorylation (YH2A.X) known to elicit recruitment and activation of many effector proteins (Figure 1) (van Attikum and Gasser, 2009). Interestingly, early work showed that after UV damage in human fibroblasts, a wave of hyperacetylation followed by subsequent deacetylation occurred on histones at a global level (Ramanathan and Smerdon, 1986). Such connection with histone acetylation has been further substantiated in the context of DSB with the Tip60 HAT complex leading to the notion that histone acetylation might assist the repair process itself and/or participate in the chromatin restoration step (van Attikum and Gasser, 2009). However, a survey to examine the specific contribution of a wide range of histone PTMs to the DDR was still missing especially in mammals.
Figure 1

A histone code for the DNA damage response in mammalian cells. After DNA damage, histones undergo many different post-translational modifications (PTMs) that can impact on the DNA repair process itself or during the chromatin restoration step. Tjeertes et al report new findings concerning changes in histone PTMs on DNA damage (marked with *). In contrast, methylation of H3K79 and H4K20 while unchanged on DSB formation rather become accessible thereby facilitating the recruitment of checkpoint signalling proteins such as 53BP1. In addition to the changes in PTMs imposed by specific enzymatic complexes (in purple), chromatin-remodelling complexes also participate in the DNA damage response by making chromatin more accessible through histone eviction or exchange (not shown). Ac, acetylation; Me, methylation; P, phosphorylation; Ub, ubiquitination. K, lysine; S, serine; Y, tyrosine.

In this issue of EMBO Journal, Tjeertes et al, using human cell lines that they subjected to various DNA damaging agents, systematically analysed changes in histone PTMs with commercially available PTM-specific histone antibodies. They report a global reduction of H3K9ac and H3K56ac on DNA damage and discuss the potential roles of these modifications during the DNA damage response. In contrast with many PTMs that are imposed on the free N-terminal part of histones, H3K56 acetylation, like H3K79 methylation, is located in the globular domain of histone H3. This region is close to the DNA entry–exit point of the nucleosome core particle, leading to the hypothesis that acetylation could potentially affect nucleosome stability (Groth ). Although until recently, the presence of H3K56ac in mammals had remained elusive, using both mass spectrometry and antibodies in western blot analysis, three independent groups have now detected H3K56ac in human cell lines (Das ; Xie ; Yuan ). In their survey, although 6 antibodies out of 32 proved non-specific, Tjeertes et al choose to focus on a subgroup of eight antibodies (YH2A.X, H3R2me2, H3S10p, H3S28p, H3S31p, H3K9ac, H3K14ac, H3K56ac), which showed a common response to replicative stress or to DSB-induced DNA damage. Importantly, they took into account that DNA damage induces alterations in cell-cycle progression and/or changes in transcription, and checked in each case whether changes in histone PTMs observed in their assays were a consequence of cell-cycle arrest or truly induced DNA damage effects. This analysis showed that decrease of H3S10p, H3S28p and H3s31p modifications after DNA damage simply reflected the cell-cycle arrest and depletion in mitotic cells in which these modifications are normally highly represented (Figure 1) (Tjeertes ). However, H3K9ac and H3K56ac levels, under their experimental conditions and in the cell line studied, did not change significantly during cell cycle nor on transcription inhibition, yet they were reduced after damage. In yeast, H3K56ac is upregulated in S-phase (Groth ), whereas in human cells this is a matter of debate (Yuan ). Thus, the extent to which H3K56ac properties in Saccharomyces cerevisiae can apply to mammals will have to be examined closer. It will surely be important to take into account the physiological state of the cells, as senescence state or aging may possibly affect the observations. Future studies should shed light on these issues. In S. cerevisiae, acetylation of H3K56 depends on the complex containing Rtt109 HAT (KAT11) together with a histone chaperone, Vps75 (a Nap-1-related protein) or Asf1. Interestingly, Rtt109 can also catalyse H3K9 acetylation in S. cerevisiae, in addition to Gcn5 (KAT2A) (Corpet and Almouzni, 2009). Here, Tjeertes et al show that human Gcn5 can act as an acetyltransferase for both H3K9 and H3K56 in vitro on recombinant histone H3. They further provide arguments in vivo by RNAi depletion experiments on human cells in culture, even though possible indirect effects may explain results in RNA interference. Given the potential structural homology between S. cerevisiae Rtt109 and human p300 (Tang ), the human HAT p300 has to be also considered as a candidate. Interestingly, Das et al show that the simultaneous knockdown of two human HATs, p300 and CBP, leads to a major decrease in H3K56ac levels. However, DNA damage induced by p300 knockdown in Tjeertes work prevented further analysis. How these multiple HATs act on H3K56ac in mammalian cells will be an interesting issue to explore. The present work enabled to specifically assign changes in histone PTMs to the presence of DNA damage per se at least for a set of modifications (Figure 1). Although extending these studies to other modifications will be an obvious next step, determining the functional importance of these changes in the DDR pathway represents a major challenge for future research. The parallel changes in H3K9 and K56 acetylation suggest a possible linked regulation and function. This is reminiscent of the diacetylation of H4 at lysines 5 and 12, typical of newly synthesized histones (Loyola and Almouzni, 2007), which has been reported at DSB sites. Whether drop in the levels of H3K9 and K56 aceylation levels reflect events related to nucleosome assembly or rather relate to signalling pathways downstream of DSB, remains to be determined. An example of decrease in a modification on DNA damage is the phosphorylation of tyrosine 142 on H2A.X (Y142 P) (Xiao ). This modification, imposed by WSTF, was proposed to regulate the maintenance/disappearance rate of YH2A.X (Xiao ). A comparison with H3K9ac and K56ac awaits further characterization of the kinetics of their variations on DNA damage. The global reduction in acetylation levels at H3K9 and K56 could also reflect a short-term effect due to the loss of histones from the DSB site followed by their subsequent degradation. As new histones can be incorporated at DSB sites after repair in human cells (Groth ), one could also imagine that H3K9ac and H3K56ac levels would increase on chromatin at later time points after completion of DNA damage repair. Nevertheless, a careful comparison of cell lines, their physiological condition (passage number), antibodies, extract preparation and damage treatment will be necessary to fully comprehend how H3K56ac, and any other modification to consider, behave during the DNA damage response in mammals and reconcile contradictory findings reported on H3K56ac levels upon DNA damage in the recent literature (Das ; Tjeertes ; Yuan ). Overall, at this point in time, a take home message is certainly to be extremely careful with commercially available antibodies, and to distinguish changes that relate to cell cycle or transcription with a specific code for the DNA damage response or any other signal one wants to study. This work will undoubtedly set the stage to investigate in a specific way the importance of key modifications related to DNA damage. Further experiments using advanced mass spectrometry should help confirm this first screening approach and, therefore, deepen our understanding of histone PTMs in relation to DDR, which we have only begun to unravel.
  11 in total

Review 1.  Chromatin challenges during DNA replication and repair.

Authors:  Anja Groth; Walter Rocha; Alain Verreault; Geneviève Almouzni
Journal:  Cell       Date:  2007-02-23       Impact factor: 41.582

Review 2.  Marking histone H3 variants: how, when and why?

Authors:  Alejandra Loyola; Geneviève Almouzni
Journal:  Trends Biochem Sci       Date:  2007-08-30       Impact factor: 13.807

Review 3.  Making copies of chromatin: the challenge of nucleosomal organization and epigenetic information.

Authors:  Armelle Corpet; Geneviève Almouzni
Journal:  Trends Cell Biol       Date:  2008-11-20       Impact factor: 20.808

Review 4.  Crosstalk between histone modifications during the DNA damage response.

Authors:  Haico van Attikum; Susan M Gasser
Journal:  Trends Cell Biol       Date:  2009-04-01       Impact factor: 20.808

5.  Changes in nuclear protein acetylation in u.v.-damaged human cells.

Authors:  B Ramanathan; M J Smerdon
Journal:  Carcinogenesis       Date:  1986-07       Impact factor: 4.944

6.  Histone h3 lysine 56 acetylation is linked to the core transcriptional network in human embryonic stem cells.

Authors:  Wei Xie; Chunying Song; Nicolas L Young; Adam S Sperling; Feng Xu; Rupa Sridharan; Anne E Conway; Benjamin A Garcia; Kathrin Plath; Amander T Clark; Michael Grunstein
Journal:  Mol Cell       Date:  2009-02-27       Impact factor: 17.970

7.  Screen for DNA-damage-responsive histone modifications identifies H3K9Ac and H3K56Ac in human cells.

Authors:  Jorrit V Tjeertes; Kyle M Miller; Stephen P Jackson
Journal:  EMBO J       Date:  2009-04-30       Impact factor: 11.598

8.  CBP/p300-mediated acetylation of histone H3 on lysine 56.

Authors:  Chandrima Das; M Scott Lucia; Kirk C Hansen; Jessica K Tyler
Journal:  Nature       Date:  2009-03-08       Impact factor: 49.962

9.  WSTF regulates the H2A.X DNA damage response via a novel tyrosine kinase activity.

Authors:  Andrew Xiao; Haitao Li; David Shechter; Sung Hee Ahn; Laura A Fabrizio; Hediye Erdjument-Bromage; Satoko Ishibe-Murakami; Bin Wang; Paul Tempst; Kay Hofmann; Dinshaw J Patel; Stephen J Elledge; C David Allis
Journal:  Nature       Date:  2008-12-17       Impact factor: 49.962

10.  Fungal Rtt109 histone acetyltransferase is an unexpected structural homolog of metazoan p300/CBP.

Authors:  Yong Tang; Marc A Holbert; Hugo Wurtele; Katrina Meeth; Walter Rocha; Marlene Gharib; Eva Jiang; Pierre Thibault; Alain Verreault; Alain Verrault; Philip A Cole; Ronen Marmorstein
Journal:  Nat Struct Mol Biol       Date:  2008-06-22       Impact factor: 15.369

View more
  12 in total

1.  UHRF1 Links the Histone code and DNA Methylation to ensure Faithful Epigenetic Memory Inheritance.

Authors:  Christian Bronner; Guy Fuhrmann; Frédéric L Chédin; Marcella Macaluso; Sirano Dhe-Paganon
Journal:  Genet Epigenet       Date:  2010-01-14

2.  Characterization of histone post-translational modifications during virus infection using mass spectrometry-based proteomics.

Authors:  Katarzyna Kulej; Daphne C Avgousti; Matthew D Weitzman; Benjamin A Garcia
Journal:  Methods       Date:  2015-06-17       Impact factor: 3.608

3.  Cigarette smoke induces distinct histone modifications in lung cells: implications for the pathogenesis of COPD and lung cancer.

Authors:  Isaac K Sundar; Michael Z Nevid; Alan E Friedman; Irfan Rahman
Journal:  J Proteome Res       Date:  2013-12-13       Impact factor: 4.466

Review 4.  Clinically Applicable Inhibitors Impacting Genome Stability.

Authors:  Anu Prakash; Juan F Garcia-Moreno; James A L Brown; Emer Bourke
Journal:  Molecules       Date:  2018-05-13       Impact factor: 4.411

5.  Histone deacetylase inhibition redistributes topoisomerase IIβ from heterochromatin to euchromatin.

Authors:  Ian G Cowell; Nikolaos Papageorgiou; Kay Padget; Gary P Watters; Caroline A Austin
Journal:  Nucleus       Date:  2011 Jan-Feb       Impact factor: 4.197

6.  Human HDAC1 and HDAC2 function in the DNA-damage response to promote DNA nonhomologous end-joining.

Authors:  Kyle M Miller; Jorrit V Tjeertes; Julia Coates; Gaëlle Legube; Sophie E Polo; Sébastien Britton; Stephen P Jackson
Journal:  Nat Struct Mol Biol       Date:  2010-08-29       Impact factor: 15.369

7.  HP1alpha recruitment to DNA damage by p150CAF-1 promotes homologous recombination repair.

Authors:  Céline Baldeyron; Gaston Soria; Danièle Roche; Adam J L Cook; Geneviève Almouzni
Journal:  J Cell Biol       Date:  2011-04-04       Impact factor: 10.539

8.  Incorporation of a histone mutant with H3K56 site substitution perturbs the replication machinery in mouse embryonic stem cells.

Authors:  Xuan Kang; Xiaomei Yang; Xiaobo Guo; Yabin Li; Chenxin Yang; Huimin Wei; Jianfeng Chang
Journal:  J Mol Cell Biol       Date:  2022-07-05       Impact factor: 8.185

9.  Ionizing radiation-induced foci persistence screen to discover enhancers of accelerated senescence.

Authors:  Edwardine Labay; Elena V Efimova; Benjamin K Quarshie; Daniel W Golden; Ralph R Weichselbaum; Stephen J Kron
Journal:  Int J High Throughput Screen       Date:  2011-03

10.  Cross-species functional genomic analysis identifies resistance genes of the histone deacetylase inhibitor valproic acid.

Authors:  Rakel Brendsdal Forthun; Tanima Sengupta; Hanne Kim Skjeldam; Jessica Margareta Lindvall; Emmet McCormack; Bjørn Tore Gjertsen; Hilde Nilsen
Journal:  PLoS One       Date:  2012-11-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.